Numis Securities restated their buy rating on shares of Huntsworth (LON:HNT) in a research note published on Wednesday. Numis Securities currently has a GBX 102 ($1.41) price objective on the stock.

Separately, Peel Hunt raised their price objective on shares of Huntsworth from GBX 80 ($1.11) to GBX 95 ($1.31) and gave the stock a buy rating in a research note on Thursday, December 14th.

Shares of Huntsworth (LON HNT) opened at GBX 76 ($1.05) on Wednesday. The stock has a market cap of $256.87 and a price-to-earnings ratio of -7,600.00. Huntsworth has a 52 week low of GBX 40 ($0.55) and a 52 week high of GBX 86.80 ($1.20).

ILLEGAL ACTIVITY WARNING: “Huntsworth (HNT) Rating Reiterated by Numis Securities” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at

About Huntsworth

Huntsworth plc is a United Kingdom-based public relations and integrated healthcare communications company. The Company operates through segments, including Citigate, Grayling, Huntsworth Health and Red. Citigate offers communications services, including global financial, investor relations, corporate, consumer and public policy communications consultancy with an integrated network across the United Kingdom, Europe, the United States and Asia.

Receive News & Ratings for Huntsworth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsworth and related companies with's FREE daily email newsletter.